During the past decade, Akagaki Clinic conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Akagaki Clinic" are "Anemia" (1 trials), "End-stage Renal Disease" (1 trials), "Hemodiafiltration" (1 trials), "Hemodialysis" (1 trials) and "Prevention of Thromboembolic Events" (1 trials). Many other conditions were trialed in "Akagaki Clinic" in a lesser frequency.

Most popular intervention types in "Akagaki Clinic" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "BAY1213790 (Osocimab)" (1 trials), "Darbepoetin alfa" (1 trials), "Molidustat (BAY85-3934)" (1 trials), "Placebo" (1 trials) and "Placebo of Darbepoetin alfa" (1 trials). Other intervention names were less common.

The vast majority of trials in "Akagaki Clinic" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Akagaki Clinic". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Akagaki Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Akagaki Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".